The present study evaluated the pharmacological effects of RGLS on depression-like behavior in ICV-STZ rats and explored related mechanisms from the perspective of NF-κB/NLRP3-mediated neuroinflammation and neuroplasticity. This evidence concerns the gene NFKB1 and depressive symptom measurement.